|
시장보고서
상품코드
2055321
임상시험수탁기관(CRO) 시장 : 서비스 유형별, 치료 영역별, 최종사용자별, 지역별Contract Clinical Research Organization Market, By Service Type, By Therapeutic Area, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
임상시험수탁기관(CRO) 시장은 2026년 962억 달러로 추정되며, 2033년까지 1,839억 5,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 9.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 962억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.70% | 2033년 시장 규모 예측 : | 1,839억 5,000만 달러 |
세계 계약 임상 연구 기관(CRO) 시장은 최근 몇 년간 꾸준한 성장을 거듭하고 있습니다. CRO란, 계약 기반으로 연구 서비스를 외부에 위탁하는 방식으로 제약, 바이오기술, 의료기기 업계를 지원하는 기업을 말합니다. CRO는 임상시험 설계, 데이터 관리, 생물통계학적 분석, 약사 규제 대응 서비스 및 기타 서비스를 제공합니다. 신약 개발 및 개발 프로세스의 진화로 인해 제약 기업의 연구가 더욱 복잡해지고 비용도 증가함에 따라, 연구 활동의 외부 위탁이 불가피한 상황입니다. 또한, 의약품 개발 주기의 단축으로 인해 다양한 치료 분야에 걸친 전문 지식과 인프라를 갖춘 외부 서비스 제공업체에 대한 수요가 증가하고 있습니다. 이러한 요인들이 계약 임상 연구 기관(CRO) 시장의 성장을 크게 견인하고 있습니다.
시장 역학
제약 기업의 연구개발(R&D) 비용 증가와 전략적 아웃소싱의 확산이 전 세계 계약 임상 연구 기관(CRO) 시장을 크게 견인하고 있습니다. 또한, 전문적인 임상시험 서비스에 대한 수요 증가와 첨단 기술의 급속한 발전이 이 시장에 새로운 기회를 창출하고 있습니다. 그러나 엄격한 규제와 승인까지 걸리는 기간의 장기화가 큰 과제로 대두되고 있습니다. 게다가, 지적재산권(IP) 및 데이터 보안과 관련된 리스크가 시장 성장을 어느 정도 억제하고 있습니다. 현재 제약사들은 경쟁 우위를 확보하기 위해 품질, 전문 지식 및 첨단 기술을 원동력으로 하는 CRO의 혁신적인 서비스 모델을 도입하고 있습니다. 이를 통해 향후 몇 년 동안 새로운 길이 열릴 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 계약 임상 연구 기관(CRO) 시장의 주요 기업 프로파일을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 애널리스트를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 계약형 임상연구기관(CRO) 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 임상시험수탁기관(CRO) 시장 : 서비스 유형별, 2021년-2033년
제5장 세계의 임상시험수탁기관(CRO) 시장 : 치료 영역별, 2021년-2033년
제6장 세계의 임상시험수탁기관(CRO) 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 임상시험수탁기관(CRO) 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.23Contract Clinical Research Organization Market is estimated to be valued at USD 96.20 Bn in 2026 and is expected to reach USD 183.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 96.20 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.70% | 2033 Value Projection: | USD 183.95 Bn |
The global contract clinical research organization market has been witnessing steady growth over the past few years. CROs are companies that support the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. They provide clinical trial design, data management, biostatistical analysis, regulatory affairs services, and other services. The evolution of drug discovery and development processes has increased research complexities and costs for pharmaceutical companies, compelling them to outsource their research activities. Moreover, abbreviated drug development cycles have increased the demand for external service providers having expertise and infrastructure across varied therapeutic areas. These factors have boosted the contract clinical research organization market growth significantly.
Market Dynamics
Rising research and development (R&D) expenditure of pharmaceutical companies along with higher adoption of outsourcing as a strategy is significantly driving the global contract clinical research organization market. Moreover, increasing demand for specialized clinical trial services and rapid evolution of advanced technologies are creating new opportunities in this market. However, stringent regulations and slower approval timelines pose major challenges. Additionally, the intellectual property (IP) rights and data security related risks restrain market growth to some extent. Pharmaceutical companies are now adopting innovative delivery models from CROs driven by quality, expertise, and advanced technologies to gain competitive advantage. This is expected to open up new avenues over the coming years.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global contract clinical research organization (CRO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include IQVIA, Covance, Syneos Health, PPD (Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, and Clinipace.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global contract clinical research organization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract clinical research organization market.
Market Segmentation
- Service Type Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Trial Service
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Other Therapeutic Areas
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Research & Academic Institutions
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- IQVIA
- Covance
- Syneos Health
- PPD (Pharmaceutical Product Development)
- ICON plc
- Charles River Laboratories
- Medpace
- Parexel International
- WuXi AppTec
- PRA Health Sciences
- KCR
- Celerion
- Catalent
- BioClinica
- Clinipace
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Contract Clinical Research Organization Market, By Service Type
- Global Contract Clinical Research Organization Market, By Therapeutic Area
- Global Contract Clinical Research Organization Market, By End User
- Global Contract Clinical Research Organization Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Contract Clinical Research Organization Market, By Service Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Trial Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
5. Global Contract Clinical Research Organization Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
6. Global Contract Clinical Research Organization Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
- Research & Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033, (USD Bn)
7. Global Contract Clinical Research Organization Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022- 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2022 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2022 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Covance
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PPD (Pharmaceutical Product Development)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PRA Health Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celerion
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Catalent
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioClinica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clinipace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About Us
